Cardioplegia strategy in isolated CABG: a comparative evaluation of del Nido, microplegia and St. Thomas II

Mustafa Akdi1, Sinan Sabit Kocabeyoğlu1, Ümit Kervan1

  • 1Department of Cardiovascular Surgery, University of Health Sciences, Ankara Bilkent City Hospital, 06800, Cankaya, Ankara, Turkey.

Insights

Del Nido and microplegia cardioplegia solutions offer effective myocardial protection during coronary artery bypass grafting (CABG), showing better biochemical preservation than St. Thomas II. Del Nido provides practical benefits without increasing patient risk.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardioplegia Solutions

Background:

  • The optimal cardioplegia strategy for adult coronary artery bypass grafting (CABG) is debated.
  • Myocardial protection during CABG is crucial for patient outcomes.

Purpose of the Study:

  • To compare the efficacy of del Nido, microplegia, and St. Thomas II cardioplegic solutions.
  • To evaluate myocardial protection using clinical, biochemical, and echocardiographic parameters in isolated CABG.

Main Methods:

  • Prospective single-center study of 157 adult patients undergoing isolated CABG.
  • Patients were grouped by cardioplegia strategy: del Nido (n=88), microplegia (n=32), and St. Thomas II (n=37).
  • Evaluated intraoperative variables, postoperative biomarkers, organ function, echocardiography, and clinical outcomes.

Main Results:

  • Del Nido used less cardioplegia volume and doses.
  • St. Thomas II had shorter cross-clamp times but more intraoperative defibrillation and adrenaline needs.
  • Del Nido showed significantly lower troponin I and CK-MB levels postoperatively.
  • Microplegia demonstrated the least pronounced LVEF decline.
  • ICU and hospital stays were longer with St. Thomas II; morbidity and mortality were comparable.

Conclusions:

  • Del Nido and microplegia provide effective myocardial protection in CABG.
  • Both del Nido and microplegia offer superior biochemical preservation compared to St. Thomas II.
  • Del Nido cardioplegia presents practical advantages without compromising safety.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...